| For: | Wang WT, Zhao XQ, Li GP, Chen YZ, Wang L, Han MF, Li WN, Chen T, Chen G, Xu D, Ning Q, Zhao XP. Immune response pattern varies with the natural history of chronic hepatitis B. World J Gastroenterol 2019; 25(16): 1950-1963 [PMID: 31086463 DOI: 10.3748/wjg.v25.i16.1950] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i16/1950.htm |
| Number | Citing Articles |
| 1 |
Noe Rico Montanari, Ricardo Ramírez, Abhishek Aggarwal, Nick van Buuren, Michael Doukas, Christina Moon, Scott Turner, Lauri Diehl, Li Li, Jose D. Debes, Becket Feierbach, Andre Boonstra. Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection. Journal of Hepatology 2022; 77(2) doi: 10.1016/j.jhep.2022.02.016
|
| 2 |
Nada Mohamed Hassan Amien, Ayman Ali Mohammed Alameen, Kashaf Junaid, Abualgasim Elgaili Abdalla, Mona O.A. Awadelkarim, Hind M. Siddig, Naser Eldin Bilal. Association of Serum 25(OH)D Deficiency with High Viral Load in HBV Infected Patients. Journal of Pure and Applied Microbiology 2022; 16(3) doi: 10.22207/JPAM.16.3.02
|
| 3 |
Ailyn Fadriquela, Cheol-Su Kim, Kyu-Jae Lee, Seong Hee Kang, Moon Young Kim, Jong-Han Lee. Soluble type immune checkpoint regulators using multiplex luminex immunoassay in chronic hepatitis B patients. Journal of Clinical Pathology 2021; 74(12) doi: 10.1136/jclinpath-2020-207125
|
| 4 |
Junhua Xie, Jun Lai, Yanzhe Zhang, Ye Liu, Zhixiang Yan. Proteomics Insight into the Pathogenic Evolution of Chronic Hepatitis B across Distinct Clinical Stages. Journal of Proteome Research 2026; 25(2) doi: 10.1021/acs.jproteome.5c00750
|
| 5 |
Dafeng Liu, Lingyun Zhou, Xinyi Zhang, Yilan Zeng, Lang Bai, Dongbo Wu, Hong Tang, Arturo Bevilacqua. Significantly Decreased Islet β Cell Function is Closely Associated with Hyperglycemia in Chronic Hepatitis B Patients. International Journal of Endocrinology 2021; 2021 doi: 10.1155/2021/1264707
|
| 6 |
Marina Campos-Valdez, Hugo C. Monroy-Ramírez, Juan Armendáriz-Borunda, Laura V. Sánchez-Orozco. Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability. Viruses 2021; 13(6) doi: 10.3390/v13061167
|
| 7 |
María B Pisano, Cecilia G Giadans, Diego M Flichman, Viviana E Ré, María V Preciado, Pamela Valva. Viral hepatitis update: Progress and perspectives . World Journal of Gastroenterology 2021; 27(26): 4018-4044 doi: 10.3748/wjg.v27.i26.4018
|
| 8 |
Wen-Xin Wang, Rui Jia, Xue-Yuan Jin, Xiaoyan Li, Shuang-Nan Zhou, Xiao-Ning Zhang, Chun-Bao Zhou, Fu-Sheng Wang, Junliang Fu. Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1121778
|
| 9 |
Florian van Bömmel, Thomas Berg. Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B. Hepatology Communications 2021; 5(10) doi: 10.1002/hep4.1708
|
| 10 |
Yingzhi Zhou, Yi He, Yunan Chang, Xiaorong Peng, Ruiqiu Zhao, Mingli Peng, Peng Hu, Hong Ren, Min Chen, Hongmei Xu. The Characteristics of Natural Killer Cells and T Cells Vary With the Natural History of Chronic Hepatitis B in Children. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.736023
|
| 11 |
Chao Zhang, Jiesheng Li, Yongqian Cheng, Fanping Meng, Jin-Wen Song, Xing Fan, Hongtao Fan, Jing Li, Yu-Long Fu, Ming-Ju Zhou, Wei Hu, Si-Yu Wang, Yuan-Jie Fu, Ji-Yuan Zhang, Ruo-Nan Xu, Ming Shi, Xueda Hu, Zemin Zhang, Xianwen Ren, Fu-Sheng Wang. Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients. Gut 2023; 72(1) doi: 10.1136/gutjnl-2021-325915
|
| 12 |
Paola Fisicaro, Marzia Rossi, Andrea Vecchi, Greta Acerbi, Valeria Barili, Diletta Laccabue, Ilaria Montali, Alessandra Zecca, Amalia Penna, Gabriele Missale, Carlo Ferrari, Carolina Boni. The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy. International Journal of Molecular Sciences 2019; 20(20) doi: 10.3390/ijms20205080
|
| 13 |
Shuaibu Hudu, Abdulgafar Jimoh, Kasimu Ibrahim, Ahmed Alshrari. Hepatitis B Therapeutic Vaccine: A Patent Review. Pharmaceuticals 2022; 15(12) doi: 10.3390/ph15121542
|
| 14 |
Qiudi Jiang, Yuchen Zhang, Dan Duan, Sylvie Retout, Ruchi Upmanyu, Katerina Glavini, Miriam Triyatni, Yonghong Zhu, Joseph F. Grippo, Yuyan Jin. Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu‐like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll‐like receptor 7 agonist ruzotolimod. Clinical and Translational Science 2024; 17(8) doi: 10.1111/cts.13896
|
| 15 |
F. Pellegrini, M. Burgio, V. Cicirelli, G. Diakoudi, G. Elia, A. Salvaggiulo, N. Filipponio, F. Di Profio, V. Sarchese, J.P. Cavasin, V. Dahm, N. Decaro, M. Camero, G. Lanave, J.A. Beatty, B. Di Martino, V. Martella. Dynamics of domestic cat hepatitis B virus infection in juvenile cats. Veterinary Microbiology 2026; 316 doi: 10.1016/j.vetmic.2026.110956
|
| 16 |
Hye Won Lee, Henry Lik-Yuen Chan. Unresolved issues of immune tolerance in chronic hepatitis B. Journal of Gastroenterology 2020; 55(4) doi: 10.1007/s00535-020-01665-z
|
| 17 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, Md. Helal Uddin, Md. Sakirul Islam Khan, Osamu Yoshida, Eduardo Penton, Guillen Nieto Gerardo, Yoichi Hiasa. Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical. Exploration of Medicine 2021; doi: 10.37349/emed.2021.00058
|
| 18 |
Yumeng Zhang, Maryline Bourgine, Yanmin Wan, Jieyu Song, Zongying Li, Yiqi Yu, Wangfang Jiang, Mingzhe Zhou, Cuiyuan Guo, Didier Santucci, Xiao Liang, Christian Brechot, Wenhong Zhang, Pierre Charneau, Hong Wu, Chao Qiu. Therapeutic vaccination with lentiviral vector in HBV-persistent mice and two inactive HBsAg carriers. Journal of Hepatology 2024; 80(1) doi: 10.1016/j.jhep.2023.09.019
|
| 19 |
Yiwen Shu, Sumeng Li, Yanqin Du, Xin Zheng. Anti-HBV treatment partially restores the dysfunction of innate immune cells and unconventional T cells during chronic HBV infection. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1611976
|
| 20 |
Bukhari Isah Shuaib, Usman Linda Itunu, Aminat Daud. Clinical utility of hepatitis B core-related antigen in chronic hepatitis B infection: diagnostic, prognostic, and therapeutic implications. Egyptian Liver Journal 2026; 16(1) doi: 10.1186/s43066-026-00512-9
|
| 21 |
Khalid Elyass Awadelkarim, Najem Aldin M. Osman, A. M. S. Eleragi, Abdelsalam M. A. Nail, Nadir Abuzeid, Mohamed E. Elangeeb, Elsadig Mohamed Ahmed, Jaber Ahmed Al-Faifi, Abdullah Alhalafi, Ahmed S. Doghish, Osama A. Mohammed, Benjamin M. Liu. Chronic active and chronic inactive hepatitis B virus infection: Comparative study of genetic polymorphism and blood profile measures. PLOS One 2025; 20(4) doi: 10.1371/journal.pone.0322268
|
| 22 |
Hui Li, Yan Wang, Shizhao Ma, Chaoqun Zhang, Hua Liu, Dianxing Sun. Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91164-9
|